focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
IT really could go either way, at this price if funding is secured and interest is shown its fair to say that there is life in this yet...the next few days should be interesting.
In the event that the process is completed as per the latest Contango (RNS) then upon completion of
legal transfer of contracts then the financial institutions will be advised of the transfer of assets and the
reverse transfer should be completed. Nominee holders and Crest will be advised and the holders of CGH
Shares will be amalgamated into the new entity at whatever share denominations have been agreed.
Bottom Line- if this happens with a listing to the MAIN market in October we should realize some value for our
shares.
Contango holdings, PR & Financial advisors....
The process is being worked on...notification to financial institutions once concluded...
Yes.Once legal paperwork completed we should receive notification of the
Number of shares all CGH shareholders will be issued with in the new listed entity. As CGH is the larger of the two companies this will be constituted as a reverse takeover. New shares will be at 5p.
The market cap is still only 3m...ratification approval will ensure mcap is multiples of its current position.
As predicted the share price will in all likelyhood maintain its downward momentum. There are no catalysts between now and 2020 to generate a bull run.
Hi Brom,
Within the public domain there are a number of Market commentators that provide indicators and analysis for 88e.
I am sure you are aware of these ...
I have been monitoring multi-sites to gain a perspective.
All the Best FG
The price has been drifting ever since the announcement ..........
The details relating to the farm out have in the most part been favourably, accepted by
market commentaries and indeed I believe that the often quoted transformational news
that DW has previously envisaged may well come true during Q 1 2020.
However we are in the realms of short term traders and market makers whose vision of
Q1 2020 is light years away.
Unless we have some short term catalysts (Ie moniterisation of Yukon -HRZ) then there is
every likelihood the price will drift.
I am very relaxed about 88e's current position as for once I believe that the company has a future
that may well become transformational during the early part of 2020.
The key with any share is the buy in period - I just happen to believe that without further catalysts
and with several months until we gain some serious news then there is every chance that the price will
drift. I could be wrong and as I hold a position here I am relaxed either way.
This is now being shorted
The decline begins, its now a bear market but opportunities to top up at lower
more realistic prices...
The longevity of the company would appear to be the main aim....
But this is not necessarily in the interests of the shareholders but does maintain
the excessive salaries and the lifestyle benefits that this brings.
The farm-out as clearly shown has not provided any uplift to the share price and as
a result of prior failures only a commercial recovery of oil will be seen as a positive and
a corresponding uplift in price.
There is now a 6 month wait at least until the likely results of the drill in Q1 2020.
Interest levels are likely now to tail off until then with a potential decline in price.
Very disappointing.
The reason for the increase is because markets are increasing price before
suspension on the basis today and Monday will be the last 2 days to get in
before potential re-listing (have 6 months). Once re-listing occurs we will be
looking at 200-300% minimum in my opinion.
Yes this is potentially ....>>>>
Outlook..Operating plan capital is now expected to increase to 6.3B which
excludes 0.3b for opportunistic acquisitions,,,,
Could that be us...here's hoping...
As a PLC under companies house rules and regulations the company has 9 months from
its Financial year end date (Which in the case of Carclo- is 31st March 2019) to file its
year end accounts.)
The companies positive outlook over the last few weeks with Hugh expectations
on future deliveries of their products suggests that financing has been covered.
Whether this is through a JV/partnership only time will tell but the FDA are obviously keen
and the BIG pharma's may be lurking in the background. Worst case scenario a potential buyout.
There is more upside than downside in my opinion.
We won;t have to wait long now ..one way or another this will be concluded....
Will they walk off with the shareholders funds or do the honorable thing and get a
deal completed.
3 Years
Nasdaq is up 3% at present
Yes Brom, I noticed this a few weeks ago, not happy bunnies are they?